STOCK TITAN

Stitch Fix (SFIX) CTO sells 70,000 shares under Rule 10b5-1 plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Stitch Fix, Inc. Chief Product and Technology Officer Anthony Bacos reported an exercise-and-sell transaction in Class A common stock. He sold a total of 70,000 shares in open-market sales on June 22, 2026, including 20,000 shares at an average price of $4.0436 per share and 50,000 shares at $4.0316 per share, under a pre-arranged Rule 10b5-1 plan entered into on March 17, 2026.

On the same date, he exercised employee stock options for 50,000 shares of Class A common stock at an exercise price of $2.48 per share, as part of an option grant that vests in scheduled quarterly installments through future dates. Following these transactions, Bacos directly holds 1,141,994 shares of Class A common stock and 622,543 employee stock options expiring on April 1, 2034.

Positive

  • None.

Negative

  • None.
Insider Bacos Anthony
Role Chief Prod/Technology Officer
Sold 70,000 shs ($282K)
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 50,000 $0.00 --
Exercise Class A Common Stock 50,000 $2.48 $124K
Sale Class A Common Stock 50,000 $4.0316 $202K
Sale Class A Common Stock 20,000 $4.0436 $81K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 622,543 shares (Direct, null); Class A Common Stock — 1,141,994 shares (Direct, null)
Footnotes (1)
  1. This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.89 to $4.115 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.905 to $4.115 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.
Shares sold 70,000 shares Total Class A common shares sold on June 22, 2026
Sale price (block 1) $4.0436 per share Weighted average price for 20,000 shares sold
Sale price (block 2) $4.0316 per share Weighted average price for 50,000 shares sold
Options exercised 50,000 shares Employee stock options converted to Class A shares
Option exercise price $2.48 per share Exercise price for employee stock options
Shares held after 1,141,994 shares Direct Class A common stock holdings post-transaction
Options remaining 622,543 options Employee stock options outstanding after exercise
Option expiration April 1, 2034 Expiration date for remaining employee stock options
Rule 10b5-1 plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sale price financial
"The reported price in Column 4 is a weighted average sale price."
Employee Stock Option (Right to Buy) financial
"Employee Stock Option (Right to Buy) ... underlying security title: Class A Common Stock"
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion ... Exercise or conversion of derivative security"
vesting financial
"25% of the shares subject to the Option vested on June 12, 2024. The remaining shares ... shall vest ... in equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bacos Anthony

(Last)(First)(Middle)
1 MONTGOMERY STREET

(Street)
SAN FRANCISCO CALIFORNIA 94104

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Stitch Fix, Inc. [ SFIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Prod/Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/22/2026M(1)50,000A$2.481,141,994D
Class A Common Stock06/22/2026S(1)50,000D$4.0316(2)1,091,994D
Class A Common Stock06/22/2026S(1)20,000D$4.0436(3)1,071,994D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$2.4806/22/2026M(1)50,000 (4)04/01/2034Class A Common Stock50,000$0622,543D
Explanation of Responses:
1. This transaction was made pursuant to a Rule 10b5-1 plan entered into on March 17, 2026.
2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.89 to $4.115 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.905 to $4.115 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. 25% of the shares subject to the Option vested on June 12, 2024. The remaining shares subject to the Option shall vest as follows: 25% of the shares in equal quarterly installments over the next two (2) quarterly vesting dates; 33 1/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates; and 16 2/3% of the shares in equal quarterly installments over the next four (4) quarterly vesting dates, subject to the recipient's continuous service through each vesting date.
Remarks:
/s/ Casey O'Connor, Attorney-in-Fact for Anthony Bacos06/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Stitch Fix (SFIX) executive Anthony Bacos report in this Form 4?

Anthony Bacos reported selling 70,000 shares of Stitch Fix Class A common stock and exercising options for 50,000 shares. These transactions were part of routine equity activity and were executed under a pre-arranged Rule 10b5-1 trading plan.

How many Stitch Fix (SFIX) shares did Anthony Bacos sell and at what prices?

He sold 70,000 Stitch Fix Class A shares in two open-market transactions: 20,000 shares at a weighted average price of $4.0436 and 50,000 shares at $4.0316. Actual sale prices ranged between roughly $3.89 and $4.115 per share.

What stock options did Anthony Bacos exercise in Stitch Fix (SFIX)?

Bacos exercised employee stock options covering 50,000 Stitch Fix Class A shares at an exercise price of $2.48 per share. These options are part of a larger grant that vests in several quarterly installments subject to his continued service.

How many Stitch Fix (SFIX) shares does Anthony Bacos own after these transactions?

After the reported sales and option exercise, Bacos directly owns 1,141,994 shares of Stitch Fix Class A common stock. This figure reflects his post-transaction equity position disclosed in the Form 4’s non-derivative holdings section.

Does Anthony Bacos still hold Stitch Fix (SFIX) stock options after this Form 4?

Yes. Following the 50,000-share option exercise, Bacos retains 622,543 employee stock options. These options relate to Stitch Fix Class A common stock and are scheduled to expire on April 1, 2034, according to the filing details.

Were Anthony Bacos’s Stitch Fix (SFIX) stock sales pre-planned?

Yes. The filing states the sales were made pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2026. Such plans allow insiders to schedule stock trades in advance under preset instructions.